ID

26757

Descripción

Study Part: Adverse Events Week 5 PK Visit (Visit 9). An open-label, up-titration study to assess the dose proportionality of ropinirole controlled release (CR) and to demonstrate the bioequivalence of ropinirole CR (1 x 8 mg) compared to the ropinirole CR (4 x 2 mg) in Parkinson's Disease patients not receiving other dopaminergic therapies. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Phase: phase 2. Study Recruitment Status: Completed. Generic Name: ropinirole. Trade Name: Modutab, ZIPEREVE, ZEPREVE, REPREVE, ADARTREL, REQUIP,Zygara. Study Indication: Parkinson Disease. Study ID: 101468/165. Clinical Study ID: 101468/165

Palabras clave

Versiones (1)
  1. 23/10/17 23/10/17 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

23 de octubre de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Adverse Events Week 5 PK Visit (Visit 9) Ropinirole Parkinson Disease 101468/165

Inglés

Adverse Events Week 5 PK Visit (Visit 9)

1 formularios  
ADVERSE EVENTS +4.5 HOURS
Descripción

ADVERSE EVENTS +4.5 HOURS

Alias
UMLS CUI-1
C0877248
Patient Number
Descripción

Patient Number

Tipo de datos

text

Alias
UMLS CUI [1]
C1830427
Centre Number
Descripción

Centre Number

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0600091
UMLS CUI [1,2]
C0019994
Visit Date
Descripción

Visit Date

Tipo de datos

date

Alias
UMLS CUI [1]
C1320303
Has the subject experienced any Adverse Events?
Descripción

Adverse Events

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0877248
Has the subject taken any Concomitant medications?
Descripción

Concomitant medications

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2347852
ADVERSE EVENTS +12.5 HOURS
Descripción

ADVERSE EVENTS +12.5 HOURS

Alias
UMLS CUI-1
C0877248
Has the subject experienced any Adverse Events?
Descripción

Adverse Events

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0877248
Has the subject taken any Concomitant medications?
Descripción

Concomitant medications

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2347852
ADVERSE EVENTS +24.5 HOURS
Descripción

ADVERSE EVENTS +24.5 HOURS

Alias
UMLS CUI-1
C0877248
Has the subject experienced any Adverse Events?
Descripción

Adverse Events

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0877248
Has the subject taken any Concomitant medications?
Descripción

Concomitant medications

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2347852
Volver a la parte superior de la página

Similar models

Adverse Events Week 5 PK Visit (Visit 9)

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
ADVERSE EVENTS +4.5 HOURS
C0877248 (UMLS CUI-1)
Patient Number
Item
Patient Number
text
C1830427 (UMLS CUI [1])
Centre Number
Item
Centre Number
integer
C0600091 (UMLS CUI [1,1])
C0019994 (UMLS CUI [1,2])
Visit Date
Item
Visit Date
date
C1320303 (UMLS CUI [1])
Adverse Events
Item
Has the subject experienced any Adverse Events?
boolean
C0877248 (UMLS CUI [1])
Concomitant medications
Item
Has the subject taken any Concomitant medications?
boolean
C2347852 (UMLS CUI [1])
Item Group
ADVERSE EVENTS +12.5 HOURS
C0877248 (UMLS CUI-1)
Adverse Events
Item
Has the subject experienced any Adverse Events?
boolean
C0877248 (UMLS CUI [1])
Concomitant medications
Item
Has the subject taken any Concomitant medications?
boolean
C2347852 (UMLS CUI [1])
Item Group
ADVERSE EVENTS +24.5 HOURS
C0877248 (UMLS CUI-1)
Adverse Events
Item
Has the subject experienced any Adverse Events?
boolean
C0877248 (UMLS CUI [1])
Concomitant medications
Item
Has the subject taken any Concomitant medications?
boolean
C2347852 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial